Form 8-K - Current report:
SEC Accession No. 0001558370-24-014773
Filing Date
2024-11-07
Accepted
2024-11-07 09:20:24
Documents
67
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20241107x8k.htm   iXBRL 8-K 64900
2 EX-99.1 xlo-20241107xex99d1.htm EX-99.1 144179
3 EX-99.2 xlo-20241107xex99d2.htm EX-99.2 78618
4 EX-99.3 xlo-20241107xex99d3.htm EX-99.3 34615
5 GRAPHIC xlo-20241107xex99d1001.jpg GRAPHIC 1190
6 GRAPHIC xlo-20241107xex99d2g001.jpg GRAPHIC 80591
7 GRAPHIC xlo-20241107xex99d2g002.jpg GRAPHIC 358064
8 GRAPHIC xlo-20241107xex99d2g003.jpg GRAPHIC 130616
9 GRAPHIC xlo-20241107xex99d2g004.jpg GRAPHIC 240429
10 GRAPHIC xlo-20241107xex99d2g005.jpg GRAPHIC 176428
11 GRAPHIC xlo-20241107xex99d2g006.jpg GRAPHIC 114792
12 GRAPHIC xlo-20241107xex99d2g007.jpg GRAPHIC 196085
13 GRAPHIC xlo-20241107xex99d2g008.jpg GRAPHIC 122002
14 GRAPHIC xlo-20241107xex99d2g009.jpg GRAPHIC 189755
15 GRAPHIC xlo-20241107xex99d2g010.jpg GRAPHIC 108377
16 GRAPHIC xlo-20241107xex99d2g011.jpg GRAPHIC 150960
17 GRAPHIC xlo-20241107xex99d2g012.jpg GRAPHIC 213418
18 GRAPHIC xlo-20241107xex99d2g013.jpg GRAPHIC 63226
19 GRAPHIC xlo-20241107xex99d2g014.jpg GRAPHIC 101637
20 GRAPHIC xlo-20241107xex99d2g015.jpg GRAPHIC 157238
21 GRAPHIC xlo-20241107xex99d2g016.jpg GRAPHIC 147200
22 GRAPHIC xlo-20241107xex99d2g017.jpg GRAPHIC 145896
23 GRAPHIC xlo-20241107xex99d2g018.jpg GRAPHIC 147004
24 GRAPHIC xlo-20241107xex99d2g019.jpg GRAPHIC 133155
25 GRAPHIC xlo-20241107xex99d2g020.jpg GRAPHIC 172257
26 GRAPHIC xlo-20241107xex99d2g021.jpg GRAPHIC 108168
27 GRAPHIC xlo-20241107xex99d2g022.jpg GRAPHIC 148473
28 GRAPHIC xlo-20241107xex99d2g023.jpg GRAPHIC 119943
29 GRAPHIC xlo-20241107xex99d2g024.jpg GRAPHIC 54269
30 GRAPHIC xlo-20241107xex99d2g025.jpg GRAPHIC 170333
31 GRAPHIC xlo-20241107xex99d2g026.jpg GRAPHIC 107615
32 GRAPHIC xlo-20241107xex99d2g027.jpg GRAPHIC 115326
33 GRAPHIC xlo-20241107xex99d2g028.jpg GRAPHIC 118260
34 GRAPHIC xlo-20241107xex99d2g029.jpg GRAPHIC 186756
35 GRAPHIC xlo-20241107xex99d2g030.jpg GRAPHIC 188278
36 GRAPHIC xlo-20241107xex99d2g031.jpg GRAPHIC 110467
37 GRAPHIC xlo-20241107xex99d2g032.jpg GRAPHIC 177140
38 GRAPHIC xlo-20241107xex99d2g033.jpg GRAPHIC 133491
39 GRAPHIC xlo-20241107xex99d2g034.jpg GRAPHIC 230200
40 GRAPHIC xlo-20241107xex99d2g035.jpg GRAPHIC 51122
41 GRAPHIC xlo-20241107xex99d2g036.jpg GRAPHIC 154041
42 GRAPHIC xlo-20241107xex99d2g037.jpg GRAPHIC 134603
43 GRAPHIC xlo-20241107xex99d2g038.jpg GRAPHIC 110066
44 GRAPHIC xlo-20241107xex99d2g039.jpg GRAPHIC 166223
45 GRAPHIC xlo-20241107xex99d2g040.jpg GRAPHIC 201760
46 GRAPHIC xlo-20241107xex99d2g041.jpg GRAPHIC 185559
47 GRAPHIC xlo-20241107xex99d2g042.jpg GRAPHIC 114913
48 GRAPHIC xlo-20241107xex99d2g043.jpg GRAPHIC 179518
49 GRAPHIC xlo-20241107xex99d2g044.jpg GRAPHIC 162758
50 GRAPHIC xlo-20241107xex99d2g045.jpg GRAPHIC 152621
51 GRAPHIC xlo-20241107xex99d2g046.jpg GRAPHIC 184090
52 GRAPHIC xlo-20241107xex99d2g047.jpg GRAPHIC 115159
53 GRAPHIC xlo-20241107xex99d2g048.jpg GRAPHIC 126534
54 GRAPHIC xlo-20241107xex99d2g049.jpg GRAPHIC 105832
55 GRAPHIC xlo-20241107xex99d2g050.jpg GRAPHIC 129246
  Complete submission text file 0001558370-24-014773.txt   10663285

Data Files

Seq Description Document Type Size
56 EX-101.SCH xlo-20241107.xsd EX-101.SCH 3250
57 EX-101.LAB xlo-20241107_lab.xml EX-101.LAB 16579
58 EX-101.PRE xlo-20241107_pre.xml EX-101.PRE 10709
69 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20241107x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 241433499
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)